Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 9/20 | 0.48 |
| ▸ | MME | P08473 | 2/20 | 0.48 |
| ▸ | CTSD | P07339 | 2/20 | 0.47 |
| ▸ | ENPEP | Q07075 | 9/20 | 0.47 |
| ▸ | BACE2 | Q9Y5Z0 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30463290 | 0.95 | BACE1 (0.48) | BACE1MMECTSDENPEPBACE2 | |
| SCHEMBL30876809 | 0.93 | BACE1 (0.52) | BACE1MMECTSDENPEPBACE2 | |
| SCHEMBL29873713 | 0.93 | ENPEP (0.50) | BACE1ENPEP | |
| SCHEMBL30837136 | 0.92 | BACE1 (0.53) | BACE1CTSDENPEPBACE2 | |
| SCHEMBL30814697 | 0.91 | BACE1 (0.48) | BACE1MMECTSDBACE2 | |
| SCHEMBL31678833 | 0.91 | BACE1 (0.49) | BACE1CTSDENPEPBACE2 | |
| SCHEMBL7822916 | 0.91 | MME (0.55) | MMEENPEP | |
| SCHEMBL7429984 | 0.91 | MME (0.55) | MMEENPEP | |
| SCHEMBL31752207 | 0.91 | MME (0.55) | MMEENPEP | |
| SCHEMBL7429977 | 0.91 | MME (0.55) | MMEENPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260085301-A1 | COMPOSITIONS AND METHODS FOR MODIFYING GENOMES | CONFLUENCE GENETICS, LLC (US) | 2026-03-26 | — | — | US | disclosed |
| EP-4677098-A1 | ENGINEERED FURIN CLEAVAGE SEQUENCES FOR CO-EXPRESSION OF MULTIPLE GENES IN MAMMALIAN CELLS | Agency for Science, Technology and Research (SG) | 2026-01-14 | — | — | EP | disclosed |
| US-12370234-B2 | Composition comprising P53-activating peptide | SUPADELIXIR INC. (KR) | 2025-07-29 | — | — | US | disclosed |
| WO-2024186270-A1 | ENGINEERED FURIN CLEAVAGE SEQUENCES FOR CO-EXPRESSION OF MULTIPLE GENES IN MAMMALIAN CELLS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2024-09-12 | — | — | WO | disclosed |
| US-20230377610-A1 | APPARATUS, SYSTEM AND METHOD FOR ASSOCIATING ONE OR MORE FILTER FILES WITH A PARTICULAR MULTIMEDIA PRESENTATION | CLEARPLAY INC (US) | 2023-11-23 | — | — | US | disclosed |
| US-11615818-B2 | Apparatus, system and method for associating one or more filter files with a particular multimedia presentation | CLEARPLAY, INC. (US) | 2023-03-28 | — | — | US | disclosed |
| US-20230021365-A1 | COMPOSITION COMPRISING P53-ACTIVATING PEPTIDE | SUPADELIXIR INC. (KR) | 2023-01-26 | — | — | US | disclosed |
| US-20230023726-A1 | PHARMACEUTICAL COMPOSITION COMPRISING PEPTIDE THAT INHIBITS INTERACTION OF P53 AND FOXO4 | SUPADELIXIR INC. (KR) | 2023-01-26 | — | — | US | disclosed |
| EP-4074303-A2 | COMPOSITION COMPRISING P53-ACTIVATING PEPTIDE | Supadelixir Inc. (KR) | 2022-10-19 | — | — | EP | disclosed |
| US-11432043-B2 | Media player configured to receive playback filters from alternative storage mediums | CLEARPLAY, INC. (US) | 2022-08-30 | — | — | US | disclosed |
| EP-4046647-A1 | PHARMACEUTICAL COMPOSITION COMPRISING PEPTIDE THAT INHIBITS INTERACTION OF P53 AND FOXO4 | Supadelixir Inc. (KR) | 2022-08-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260085301-A1 | COMPOSITIONS AND METHODS FOR MODIFYING GENOMES | POLM, FEN1, XPA | BACE1 3719/4885MME 3338/4885CTSD 4408/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.